Multicenter study of Abbott AxSYM® Digoxin II assay and comparison with 6 methods for susceptibility to digoxin-like immunoreactive factors

Clinical Chemistry

Volumn 43, Issue 9, 1997, Pages 1635-1640

  Azzazy, Hassan M E ^a,g   Duh, Show Hong ^a   Maturen, Andrew ^b   Schaller, Elisabeth ^c   Shaw, Leslie ^d   Grimaldi, Robert ^e   Shock, Gloria ^f   Christenson, Robert H ^a  

^a Departments of Pathology   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

^d HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^e TUFTS MEDICAL CENTER   (United States)

^f ABBOTT LABORATORIES   (United States)

^g UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIGOXIN;

ARTICLE; CONGESTIVE HEART FAILURE; DIAGNOSTIC ACCURACY; DRUG BLOOD LEVEL; DRUG INTOXICATION; HEART ARRHYTHMIA; HUMAN; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY;

EID: 0030763546     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/43.9.1635     Document Type: Article

References (21)

1. Lisalo E. Clinical pharmacokinetics of digoxin. Clin Pharmacokinet 1977:2:1-16.
2. Mahdyoon H, Battilana G, Rosman H, Goldstein S, Gheorghiade M. The evolving pattern of digoxin intoxication: observations at a large urban hospital from 1980 to 1988. Am Heart J 1990;120: 1189-94.
3. Antman EM, Wenger TL, Butler VP, Haber E, Smith TW. Treatment of 150 cases of life-threatening digitalis intoxication with digoxinspecific Fab antibody fragments. Final report of a multicenter study. Circulation 1990;81:1744-52.
4. Lalonde RL, Deshpande R, Hamilton PP, McLean WM, Greenway DC. Acceleration of digoxin clearance by activated charcoal. Clin Pharmacol Ther 1985;37:367-71.
5. Valdes R Jr. Endogenous digoxin-like immunoreactive factors: impact on digoxin measurements and potential physiological implications. Clin Chem 1985:31:1525-32.
6. Soldin SJ. Digoxin-issues and controversies [Review]. Cjin Chem 1986;32:5-12.
7. Beyers AD, Spruyt LL, Seifart HI, Kriegler A, Parkin DP, Van Jaarsueld PP. Endogenous immunoreactive digitalis-like substance in neonatal serum and placental extracts. S Afr Med J 1984:65:878-82.
8. +-ATPase. Clin Biochem 1985:18:48-55.
9. Cook JD, Koch TR, Cook MS, Knoblock EC. Inaccuracies in digoxin measurement. Clin Biochem 1988;21:353-7.
10. Graves SW, Brown B, Valdes R. An endogenous digoxin-like substance in patients with renal impairment. Ann Intern Med 1983:99:604-8.
11. Pleasants RA, Gadsden RH, McCormack JP, Piveral K, Sawyer WT. Interference of digoxin-like immunoreactiye substances with three digoxin immunoassays in patients with various degrees of renal function. Clin Pharm 1986;5:810-6.
12. Nanji AA, Greenway DC. Falsely raised plasma concentrations in liver disease. Br J Med 1985:290:432-3.
13. Pudek MR, Seccombe DW, Humphries KG. Digoxin-like immunoreactive substance and bile adds in the serum of patients with liver disease [Letter]. Clin Chem 1986:32:2005-6.
14. Balzan S, Clerico A, del Chicca MG, Montali U, Ghione S. Digoxin-like immunoreactivity in normal human plasma and urine, as detected by a solid-phase radioimmunoassay. Clin Chem 1984:30:450-1.
15. Yannakou L, Diamandis EP, Souvatzoglou A. Effect of incubation time and temperature on the interference of digoxin-like immunoreactive substances in digoxin immunoassays. Ther Drug Monit 1987:9:461-6.
16. Qazzaz HMAM, Goudy S, Miller JJ, Valdes R Jr. Treatment of human serum with sulfosalicylic acid structurally alters digoxin and endogenous digoxin-like immunoreactive factors. Ther Drug Monit 1995:17:53-9.
17. Krinkle RO, Johnson GF. Estimating variance components by nested ANOVA. In: Burtis CA, Ashwood ER, eds. Tietz textbook of clinical chemistry, 2nd ed. Philadelphia: WB Saunders, 1986: 324-32.
18. Woolson RF. Statistical methods for the analysis of biomedical data. New York: Wiley and Sons, 1987:205-13.
19. Gault MH, Vasdev S, Longerich L. Higher values for digitalis-like factors with TDx Digoxin II [Letter]. Clin Chem 1986:32:2000-1.
20. Dodds HM, Norris RLG, Johnson AG, Pond SM. Evaluation and comparison of the TDx, II Stratus, and OPUS digoxin assays. Ther Drug Monit 1995:17:68-74.
21. Jortani SA, Miller JJ, Helm RA, Valdes R Jr. Unexpected suppression of digoxin values caused by DLlFs [Abstract]. Clin Chem 1996;42:S124.